Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$2.22 - $4.14 $24,475 - $45,643
-11,025 Closed
0 $0
Q2 2019

Aug 12, 2019

BUY
$2.52 - $6.5 $27,783 - $71,662
11,025 New
11,025 $26,000

Others Institutions Holding MREO

About Mereo Biopharma Group plc


  • Ticker MREO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,986,000
  • Market Cap $316M
  • Description
  • Mereo BioPharma Group plc, a biopharmaceutical company, develops and commercializes therapeutics for the treatment of oncology and rare diseases in the United Kingdom and internationally. Its lead product candidate, etigilimab (OMP-313M32), an antibody T-cell immunoreceptor with Ig and ITIM domains, which is in Phase 1b clinical trial for the tr...
More about MREO
Track This Portfolio

Track Cannell & Co. Portfolio

Follow Cannell & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.